Clinical profile of drug resistant tuberculosis in children

Indian Pediatrics

Volumn 49, Issue 9, 2012, Pages 741-744

  Shah, Ira ^a   Chilkar, Sujeet ^a  

^a B J WADIA HOSPITAL FOR CHILDREN   (India)

Author keywords

Children; Drug resistant tuberculosis; India; Outcome

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BCG VACCINE; CAPREOMYCIN; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ABDOMINAL TUBERCULOSIS; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MALE; MIXED INFECTION; MONOTHERAPY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBSERVATIONAL STUDY; PRESCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS OSTEOMYELITIS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865515783     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-012-0158-6     Document Type: Article

References (13)

1. TB India 2010: RNTCP Status report. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi - 110001. Available from: http://www.tbcindia.org. Accessed on 24 November, 2010.
2. World Health Organization (WHO). Anti-Tuberculosis Drug Resistance in the World. Fourth 'Global Report. Available at URL: http://www.who.int/tb/ publications/2008/drs-report4-26feb08.pdf. Accessed on 31December, 2011.
3. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis - 2006. Available at URL: http://www.tbrieder.org/publications/books-english/who-treatment-mdr.pdf. Accessed on 31December, 2011.
4. Shah I, Rahangdale A. Partial extensively drug resistance (XDR) tuberculosis in children. Indian Pediatr. 2011; 48:977-8.
5. World Health Organization (WHO). Guidance on providerinitiated HIV testing and counselling in health facilities. Available at URL: http://www.who.int/hiv/pub/vct/pitc/en/index.html. Accessed on 16February, 2012
6. Schaaf HS. Drug-resistant tuberculosis in children. S Afr Med J. 2007;97:995-7.
7. Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J. 2002;23:305-10.
8. Gordin FM, Nelson ET, Matts JP, Cohn DL, Ernst J, Benator D, et al. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med. 1996;154:1478-83.
9. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 1996;45:1-18.
10. Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, Jain NK, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non- HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol. 2003; 3: 183-188.
11. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5 : 887-893.
12. Snider DE Jr, Kelly GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis. 1985;132:125-32.
13. Schaaf HS, Vermeulen HA, Gie RP, Beyers N, Donald PR. Evaluation of young children in household contact with adult multidrug resistant pulmonary tuberculosis cases. Pediatr Infect Dis J. 1999;18:494-500.